WallStreetZenWallStreetZen

NASDAQ: FATE
Fate Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Fate Therapeutics revenue was $7.14M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2025) ending on Sep 30, 2025 was $1.7M, down 8.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, FATE annual revenue was $13.6M, with -78.5% growth year-over-year.

FATE past revenue growth

How has FATE's revenue growth performed historically?

Company
-46.92%
Industry
290.99%
Market
23.08%
FATE's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
FATE's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
FATE's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

FATE revenue history

Current Revenue
$7.1M
Current Earnings
-$156.1M
Current Profit Margin
-2,187.1%

Be the first to know when FATE announces revenue.

FATE Revenue History By Year

FATE Yearly RevenueFATE RevenueFATE ChangeFATE Revenue Growth
2024-12-31$13.63M-$49.90M-78.55%
2023-12-31$63.53M-$32.77M-34.03%
2022-12-31$96.30M$40.45M+72.44%
2021-12-31$55.85M$24.41M+77.66%
2020-12-31$31.43M$20.75M+194.33%
2019-12-31$10.68M$5.94M+125.32%
2018-12-31$4.74M$634.00k+15.44%
2017-12-31$4.11M-$296.00k-6.72%
2016-12-31$4.40M$1.97M+81.08%
2015-12-31$2.43MN/AN/A
2014-12-31$0.00-$971.00k-100.00%
2013-12-31$971.00k-$1.70M-63.63%
2012-12-31$2.67M$1.50M+128.21%
2011-12-31$1.17MN/AN/A

1 of 1

Fate Therapeutics Revenue FAQ

What was FATE's revenue last quarter?

On Invalid Date, Fate Therapeutics (NASDAQ: FATE) reported Q3 2025 revenue of $1.74 million up 43.36% year over year. In the same quarter last year, Fate Therapeutics's revenue was $3.07 million.

What was Fate Therapeutics's revenue in 2024?

Fate Therapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $13.63 million, a 78.55% decrease year over year.

How much does Fate Therapeutics make in a day?

Based on Fate Therapeutics annual revenue for the past five years, FATE makes an average of $142,873.42 per day.

What was Fate Therapeutics's annual revenue growth in the past year?

As of Q4 2025, Fate Therapeutics's revenue has grown -46.92% year over year. This is 337.92 percentage points lower than the US Biotechnology industry revenue growth rate of 290.99%. Fate Therapeutics's revenue in the past year totaled $7.14 million.

How much does Fate Therapeutics make in a year?

Fate Therapeutics's revenue by year for the past five years is:
  • Fate Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $13.63 million, a 78.55% decrease year over year.
  • Fate Therapeutics's annual revenue for Dec 31, 2023 was $63.53 million, a 34.03% decrease from 2022.
  • Fate Therapeutics's annual revenue for 2022 was $96.30 million, a 72.44% increase from 2021.
  • Fate Therapeutics's annual revenue for 2021 was $55.85 million, a 77.66% increase from 2020.
  • Fate Therapeutics's annual revenue for 2020 was $31.43 million, a 194.33% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.